BIOGEN IDEC $233.07

up +1.74


22/5/2013 04:22 PM  |  NASDAQ : BIIB  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
12 Mo. Price Change : 76% - BIIB has outperformed the S&P 500 by 50%

Get Trend Analysis Icon Get Trend Analysis

Partner Headlines

  1. Biogen Idec Inc (BIIB) CEO George A Scangos sells 1,598 Shares

    GuruFocus

  2. Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)

    Benzinga

  3. Biogen up on new drug news

    Investors Business Daily

  4. Biogen Hemophilia Drug News, Upgrades Lift Stock

    Investors Business Daily

  5. UPDATE: Credit Suisse Raises PT to $185 on Biogen Idec on Tysabri ...

    Benzinga

  6. Stocks Launch On Positive Note; LinkedIn, FleetCor Lead Gains

    Investors Business Daily

  7. UPDATE: Citigroup Upgrades Biogen Idec to Buy on Strong Fundamentals

    Benzinga

  8. Biogen: $3.25 Bil For MS Drug

    Investors Business Daily

  9. Market Wrap for Wednesday, February 6: Major Averages Close Near ...

    Benzinga

  10. Stocks Lower In Choppy Trade; Aruba, Trimble Slide

    Investors Business Daily

  11. Biogen Stock Hits New High On Tysabri Buyout

    Investors Business Daily

  12. Futures Dive On Earnings, Dollar; Ralph Lauren Reports Solid Q3

    Investors Business Daily

  13. Elan Agrees to Restructure Tysabri Collaboration with Biogen Idec

    Benzinga

  14. Acorda Therapeutics Could Be a Stock to Watch in 2013

    Benzinga

  15. Invest With Charts: Look For Accumulation In A Base

    Investors Business Daily

  16. A Weakening Yen Weighs on U.S. Earnings

    FOXBusiness

  17. Biogen MS Hopes Trump EPS

    Investors Business Daily

  18. Biogen Idec Stock Rises As Sales Beat Expectations

    Investors Business Daily

  19. Stocks In The Red In Mixed Trade; Stratasys, 3D Systems Plummet

    Investors Business Daily

  20. UPDATE: Biogen Idec Posts Downbeat Q4 Profit, Issues Weak 2013 ...

    Benzinga

  21. Benzinga Market Primer: Monday, January 28

    Benzinga

  22. US Stock Futures Flat Ahead Of Caterpillar Earnings

    Benzinga

  23. Earnings Scheduled For January 28, 2013

    Benzinga

  24. Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)

    Benzinga

  25. Biogen, Illumina Ready Q4 Reports As Stocks Struggle

    Investors Business Daily

  26. Celgene, ResMed, Bristol, Biogen Stocks Move On News

    Investors Business Daily

  27. Medical Stock Wrap: Celgene, Bristol, Baxter, Biogen

    Investors Business Daily

  28. Biogen Idec Announces Positive Top-Line Results from Phase 3 Study ...

    Benzinga

  29. Morgan Stanley Sees Possible Near-Term Increase in M&A, Unveils ...

    Benzinga

  30. Biogen Submits Biologics License Application to FDA for First ...

    Benzinga

  31. Biogen slips on drug failure

    Investors Business Daily

  32. Stocks Stumble, Reverse Lower On Fed Minutes

    Investors Business Daily

  33. Biogen Stock Falls After ALS Candidate Fails

    Investors Business Daily

  34. Analyst Downgrades: Biogen Idec, AT&T, and UnitedHealth Group

    By SchaeffersResearch

  35. Stocks Dip After Fed Minutes Hint At End To Bond Buying

    Investors Business Daily

  36. Biogen Drug for Lou Gehrig's Disease Flops in Trial

    YCharts

  37. Stocks Turn Slightly Up; H&E Equipment Breaks Out

    Investors Business Daily

  38. Stocks Turn Mixed As Volume Slips; Biogen Off 4%

    Investors Business Daily

  39. Biogen Stock Falls After ALS Drug Candidate Fails

    Investors Business Daily

  40. UPDATE: Piper Jaffray Downgrades Biogen Idec to Neutral on Valuation

    Benzinga

  41. Benzinga's Top Pre-Market Losers

    Benzinga

  42. Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)

    Benzinga

  43. Big Cap 20: Biogen, HCA Are Finalizing Bases

    Investors Business Daily

  44. Big Cap 20: Biogen, Comcast Are Finalizing Bases

    Investors Business Daily

  45. Analyst Upgrades: Biogen Idec, Yum! Brands, and Costco

    By SchaeffersResearch

  46. These ETFs Are Awash in 2013 Takeover Targets

    Benzinga

  47. Biogen, Eisai Announce Manufacturing Alliance at Research Triangle ...

    Benzinga

  48. Hemophilia Treatment Could Take A New Leap

    Investors Business Daily

  49. Amgen buys DeCode Genetics

    Investors Business Daily

  50. There is Life After Patent Expirations: Why Pfizer and Lilly ...

    YCharts

  51. Amgen Buying DeCode Genetics To Find Targeted Drugs

    Investors Business Daily

  52. Biogen, Isis Pharma Announce Collaboration for Antisense Programs

    Benzinga

  53. Amgen, Gilead, Regeneron Among 7 Best Biotech Stocks

    Investors Business Daily

  54. Baxter buys dialysis firm

    Investors Business Daily

  55. Baxter International Buying Gambro For $4 Billion

    Investors Business Daily

  56. Comcast, Regeneron, Biogen Idec Spur New Products

    Investors Business Daily

  57. Teva provides weak '13 outlook

    Investors Business Daily

  58. Celgene, Regeneron Pharmaceutical Lead Biomed Group

    Investors Business Daily

  59. Teva's Stock Falls After 2013 Guidance Falls Short

    Investors Business Daily

  60. Medical Stocks Still Provide Big-Cap Leadership

    Investors Business Daily

  61. Analyst Upgrades: Biogen Idec, Celgene, and Yum! Brands

    By SchaeffersResearch

  62. Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX)

    Benzinga

  63. Option Idea of the Week: Biogen Idec

    By SchaeffersResearch

  64. Biogen Idec Inc (BIIB) CEO George A Scangos sells 2,472 Shares

    GuruFocus

  65. Edward Owens' Vanguard Health Care Fund Does More Shedding Than ...

    GuruFocus

  66. Biogen Idec's hemophilia

    Investors Business Daily

  67. Novo Nordisk Beats Estimates As FDA Decision Looms

    Investors Business Daily

  68. Biogen Hemophilia Trial Meets Goals, But Stock Falls

    Investors Business Daily

  69. Biogen Idec and Sobi Announce Positive Top-Line Results from Phase ...

    Benzinga

  70. Biogen Idec Inc Reports Operating Results (10-Q)

    GuruFocus

  71. Biotechs Beat, Raise Outlook

    Investors Business Daily

  72. Short Interest Swings in Biotech Stocks (BIIB, GILD, VVUS)

    Benzinga

  73. Stocks Waver To Lower Close; Akamai Jumps After Hours

    Investors Business Daily

  74. Celgene, Biogen To Report Q3 As Pipeline Hopes Build

    Investors Business Daily

  75. Gilead, Amgen Earnings To Launch Busy Biotech Week

    Investors Business Daily

  76. Biogen slides on drug delay

    Investors Business Daily

  77. Madison Square Garden, Stratasys Catch Their Breath

    Investors Business Daily

  78. Stock Averages Lose Ground As Volume Swells

    Investors Business Daily

  79. Stocks Down; Google Lays Blame For Earnings Snafu

    Investors Business Daily

  80. Biogen Stock Slips After FDA Delays MS Drug Review

    Investors Business Daily

  81. Biogen Idec Traders Target Record Highs

    By SchaeffersResearch

  82. A Peek Into The Market Before The Trading Starts

    Benzinga

  83. Biogen Announces New Data from Phase 3 Studies for Oral BG-12 ...

    Benzinga

  84. Acorda Therapeutics Names Jane Wasman President, International

    Benzinga

  85. UPDATE: Credit Suisse Reiterates Outperform Rating, Raises PT on ...

    Benzinga

  86. Good News For Biogen's $7 Billion Rituxin: Copying Drugs Bio Drugs ...

    YCharts

  87. Analyst Downgrades: Biogen Idec, Zynga, and Coventry Health Care

    By SchaeffersResearch

  88. Tom Marsico Favors Health Care Names Like Biogen Idec

    Investors Business Daily

  89. Focusing R&D On Select Diseases Works For Biogen

    Investors Business Daily

  90. UPDATE: Stifel Nicolaus Increases PT to $168 on Biogen Idec on ...

    Benzinga

  91. Highs & Lows: Biogen Idec, Hewlett-Packard, Questcor, and VeriFone

    By SchaeffersResearch

  92. Biogen touts hemophilia study

    Investors Business Daily

  93. Stocks Lower as Euro Concerns Return

    At Market Intelligence Center

  94. Stocks Off Worst Levels, But Remain Red

    Investors Business Daily

  95. Stock Futures Point to Muted Open Ahead of Housing Data with ...

    At Market Intelligence Center

  96. UPDATE: Bank of America Raises PO to $173 on Biogen Idec on Strong ...

    Benzinga

  97. Short Interest in Biotech Firms Resumes (BIIB, GILD, ILMN, REGN)

    Benzinga

  98. Biogen Reports Good Results For Hemophilia Drug

    Investors Business Daily

  99. Stock Futures Tightly Mixed; Biogen Idec Rises

    Investors Business Daily

  100. Benzinga's Top Pre-Market Gainers

    Benzinga
People viewing BIIB also viewed: , , , , , ,
Marketplace
Trading Center